National Cancer Act of 2002
Latest action · May 21, 2002 Sponsor introductory remarks on measure. (CR S4615)
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 28, 2002
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Amends the Public Health Service Act to fund prevention and treatment programs of the National Cancer Institute, including translational cancer research (research needed to transform scientific discoveries into approaches and products to treat and cure cancer).
Addresses issues of cancer care, including: (1) clinical trial participation; (2) workforce needs; (3) Medicare coverage; (4) protocols and guidelines; (5) National Program of Comprehensive Cancer Control Plans; (5) the supply of researchers; (6) environmental risk factors research; and (7) a colorectal cancer screening demonstration program.
Requires health insurance plans covered by the Public Health Service Act and the Employee Retirement Income Security Act of 1974 to provide: (1) coverage for clinical trials; (2) coverage of cancer screening, including tobacco and nutrition counseling and genetic testing; and (3) patient access to benefit information.
Addresses issues of managing physicians and quality of care for cancer patients covered by such plans, including designating a lead managing physician.
Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to regulate tobacco products. Sets forth requirements pertaining to: (1) adulteration; (2) misbranding; (3) the submission of health information; (4) annual registration and biennial inspection of processors; (5) biannual reporting of product list changes; (6) good manufacturing practices; (7) product performance standards; (8) information, notification, and other remedies; (9) records and reports; (10) premarket review; (11) judicial review; (12) postmarket surveillance; (13) reduced risk tobacco products; (14) preservation of State and local authority; and (15) equal treatment of retail outlets.
Amends the Federal Cigarette Labeling and Advertising Act to: (1) revise cigarette labeling, advertising, and marketing requirements; and (2) authorize the Secretary to require disclosure of tar, nicotine, and other smoke constituents on package labels and/or advertisements.
Amends the Comprehensive Smokeless Tobacco Health Education Act of 1986 to revise smokeless tobacco warning label and advertising requirements.
Cosponsors 29
Members who signed on, in the order they did. All signed on Feb 28, 2002.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MD | Barbara A. Mikulski | Original | Feb 28, 2002 |
| D-CA | Barbara Boxer | Original | Feb 28, 2002 |
| D-NE | Ben Nelson | Original | Feb 28, 2002 |
| D-FL | Bill Nelson | Original | Feb 28, 2002 |
| D-AR | Blanche L. Lincoln | Original | Feb 28, 2002 |
| D-FL | Bob Graham | Original | Feb 28, 2002 |
| D-NY | Charles E. Schumer | Original | Feb 28, 2002 |
| D-CT | Christopher J. Dodd | Original | Feb 28, 2002 |
| D-MI | Debbie Stabenow | Original | Feb 28, 2002 |
| R-OR | Gordon H. Smith | Original | Feb 28, 2002 |
| D-NV | Harry Reid | Original | Feb 28, 2002 |
| D-NY | Hillary Rodham Clinton | Original | Feb 28, 2002 |
| D-RI | Jack Reed | Original | Feb 28, 2002 |
| R-VT | James M. Jeffords | Original | Feb 28, 2002 |
| D-MO | Jean Carnahan | Original | Feb 28, 2002 |
| D-LA | John B. Breaux | Original | Feb 28, 2002 |
| D-MA | John F. Kerry | Original | Feb 28, 2002 |
| D-NJ | Jon S. Corzine | Original | Feb 28, 2002 |
| R-TX | Kay Bailey Hutchison | Original | Feb 28, 2002 |
| R-RI | Lincoln Chafee | Original | Feb 28, 2002 |
| D-WA | Maria Cantwell | Original | Feb 28, 2002 |
| D-LA | Mary L. Landrieu | Original | Feb 28, 2002 |
| R-ME | Olympia J. Snowe | Original | Feb 28, 2002 |
| D-VT | Patrick J. Leahy | Original | Feb 28, 2002 |
| D-WA | Patty Murray | Original | Feb 28, 2002 |
| D-NJ | Robert G. Torricelli | Original | Feb 28, 2002 |
| R-ME | Susan M. Collins | Original | Feb 28, 2002 |
| D-SD | Thomas A. Daschle | Original | Feb 28, 2002 |
| D-SD | Tim Johnson | Original | Feb 28, 2002 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Feb 28, 2002 |
Actions 4
Everything that happened, newest first.
- May 21, 2002Sponsor introductory remarks on measure. (CR S4615)
- Feb 28, 2002Introduced in Senate
- Feb 28, 2002Sponsor introductory remarks on measure. (CR S1361-1364)
- Feb 28, 2002Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S4615 | Dianne Feinstein D-CA | May 21, 2002 |
| Senate | Debate and remarks S1361–S1365 | Dianne Feinstein D-CA, Gordon H. Smith R-OR, Hillary Rodham Clinton D-NY | Feb 28, 2002 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to provide for a comprehensive Federal effort relating to treatments for, and the prevention of cancer, and for other purposes.
- Short Titles as Introduced
- National Cancer Act of 2002
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Access to health care
- Administrative procedure
- Administrative remedies
- Advertising
- Agriculture and Food
- Armed Forces and National Security
- Breast cancer
- Business income tax
- Business records
- Cancer
- Cancer research
- Case management
- Cervical cancer
- Chemotherapy
- Cigarettes
- Civil Rights and Liberties, Minority Issues
- Clinical trials
- Coinsurance
- Colon cancer
- Commerce
- Commercialization
- Communication in medicine
- Congress
- Congressional oversight
- Consumer education
- Deceptive advertising
- Defective products
- Department of Health and Human Services
- Discrimination in insurance
- Discrimination in medical care
- Drug abuse
- Drug abuse counseling
- Drug adulteration
- Drug approvals
- Drug industry
- Drug law and legislation
- Economics and Public Finance
- Education
- Employee health benefits
- Environmental health
- Environmental Protection
- Environmental research
- Environmental risk assessment
- Families
- Family services
- Federal aid to child health services
- Federal aid to medical education
- Federal aid to medical research
- Federal aid to nursing education
- Federal employees
- Federal preemption
- Finance and Financial Sector
- Foreign Trade and International Finance
- Freedom of information
- Genetic counseling
- Genetic research
- Genetic screening
- Government employees' health insurance
- Government Operations and Politics
- Government paperwork
- Government publicity
- Governmental investigations
- Health
- Health counseling
- Health education
- Health information systems
- Health insurance
- Health planning
- Health warnings
- Higher education
- Home care services
- Hospices (Terminal care)
- Human behavior
- Human genetics
- Identification devices
- Imaging systems in medicine
- Imports
- Income tax
- Indian medical care
- Judicial review of administrative acts
- Labeling
- Labor and Employment
- Language and languages
- Law
- Licenses
- Local laws
- Lung cancer
- Lung diseases
- Mammography
- Marketing
- Marketing research
- Medicaid
- Medical economics
- Medical genetics
- Medical records
- Medical screening
- Medical statistics
- Medical technology
- Medical tests
- Medically uninsured
- Medicare
- Military medicine
- Minorities
- Minorities in medicine
- Minority education
- Nicotine
- Nonprofit organizations
- Nutrition
- Orphan drugs
- Packaging
- Pain
- Patients' rights
- Peace Corps
- Pharmaceutical research
- Physical examinations
- Physicians
- Poor children
- Preventive medicine
- Product safety
- Prostate cancer
- Quality of care
- Quality of life
- Quality of products
- Rebates
- Research and development
- Research centers
- Restrictive trade practices
- Retail trade
- Scholarships
- Science, Technology, Communications
- Smokeless tobacco
- Smoking
- Social Welfare
- State laws
- Strategic planning
- Student loan funds
- Taxation
- Technological innovations
- Terminal care
- Tobacco
- Tobacco industry
- Tobacco research
- Warning labels
- Women
- Women's health
Text 1
Each version as it was printed, newest first.
- Feb 28, 2002Introduced in Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.